Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial

BACKGROUND: In the SafeBoosC-III trial, treatment guided by cerebral oximetry monitoring for the first 72 hours after birth did not reduce the incidence of death or severe brain injury in extremely preterm infants at 36 weeks’ postmenstrual age, as compared with usual care. Despite an association be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Marie Isabel, Hansen, Mathias Lühr, Pellicer, Adelina, Gluud, Christian, Dempsey, Eugene, Mintzer, Jonathan, Hyttel-Sørensen, Simon, Heuchan, Anne Marie, Hagmann, Cornelia, Ergenekon, Ebru, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Cheng, Guoqiang, Tkaczyk, Jakub, Fuchs, Hans, Fumagalli, Monica, Nesargi, Saudamini, Fredly, Siv, Szczapa, Tomasz, Plomgaard, Anne Mette, Hansen, Bo Mølholm, Jakobsen, Janus Christian, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560418/
https://www.ncbi.nlm.nih.gov/pubmed/37805539
http://dx.doi.org/10.1186/s13063-023-07653-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560418/
https://www.ncbi.nlm.nih.gov/pubmed/37805539
http://dx.doi.org/10.1186/s13063-023-07653-x

Ejemplares similares